{
  "id": "allergen",
  "title": "Allergen",
  "lang": "en",
  "source_lang": "en",
  "summary": "An allergen is a substance that can provoke a specific immune-mediated allergic reaction in a susceptible individual.",
  "category": "science",
  "subcategory": "biology",
  "type": "concept",
  "aliases": [
    "Allergenic substance"
  ],
  "generated_at": "2026-10-25",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/allergen/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/allergen/",
      "json": "https://aiwiki.page/zh/allergen.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "An allergen is a substance recognized by the immune system that can trigger an allergic reaction in a susceptible individual. Many well-characterized allergens are proteins from pollen, house dust mites, foods, animals, fungi, or insect venoms. Other substances, including certain metals and chemicals, can cause allergy through different forms of immune recognition. Allergenicity is not an intrinsic measure of toxicity: a substance tolerated by most people may cause an allergic reaction in someone who has become sensitized to it.\n\nIn immediate allergic reactions, allergen-specific immunoglobulin E (IgE) antibodies participate in the activation of mast cells and basophils, releasing mediators that produce symptoms. Other allergic reactions, notably allergic contact dermatitis, involve T cells rather than IgE. Exposure can occur through inhalation, ingestion, skin contact, injection, or insect stings, and its consequences depend on the allergen, route, and individual. Sensitization—the development of a specific immune response—does not necessarily mean that exposure causes clinical disease.\n\nIdentifying and characterizing allergens connects molecular immunology with clinical diagnosis, environmental monitoring, food safety, and occupational health. Allergen research explains cross-reactivity between apparently unrelated sources, supports standardized diagnostic materials, and provides the basis for allergen-specific immunotherapy. The distinction between an allergenic source, its individual molecular components, and a clinically relevant allergic response is central to these applications."
    },
    {
      "heading": "Definition, Scope, and Terminology",
      "text": "An allergen is an antigen that elicits allergic hypersensitivity: an immune-mediated reaction that produces symptoms or signs in a susceptible individual. An antigen is a structure recognized specifically by antibodies or antigen receptors on lymphocytes; recognition alone does not make it an allergen. Most familiar allergens are proteins, but other molecular structures can also participate in allergic responses. Allergenicity is therefore not simply an intrinsic measure of toxicity: it describes a substance’s capacity to elicit a particular immune response in a susceptible host. A substance tolerated by most people can nevertheless provoke allergic rhinitis, contact dermatitis, or another allergic disorder in sensitized individuals.\n\nAllergy is distinguished from adverse effects that do not depend on antigen-specific immunity. Irritation can result from direct effects on tissues, as with eye irritation from airborne chemicals; toxicity reflects harmful biological effects of a substance and does not require prior immune sensitization. Nonimmune food intolerance likewise differs from food allergy. In lactose intolerance, insufficient intestinal lactase activity leaves lactose incompletely digested, contributing to osmotic effects and bacterial fermentation rather than an immune response against milk proteins. Similar symptoms can arise through different mechanisms: wheezing, skin redness, or gastrointestinal discomfort does not, by itself, establish that an allergen is responsible.\n\nAn allergenic source is the organism, material, or product from which allergens originate, whereas an allergenic molecule is an individual immune-recognized constituent. A peanut is a source containing several allergenic proteins, including Ara h 1 and Ara h 2; the house dust mite Dermatophagoides pteronyssinus produces molecules designated Der p 1 and Der p 2. Accordingly, “peanut allergen” or “mite allergen” may refer loosely to source material, an extract containing multiple constituents, or a particular molecule. These meanings are not interchangeable. People sensitized to the same source may recognize different molecular components, and related components from different sources may share epitopes, the structures recognized by antibodies or immune-cell receptors.\n\nSensitization is the establishment of specific immune responsiveness to an allergen; it is not synonymous with symptomatic disease. In immediate-type allergy, sensitization is commonly demonstrated by detecting allergen-specific immunoglobulin E (IgE) in serum or by an immediate skin-test response. Such findings establish immune recognition, not necessarily symptoms following ordinary exposure. Recognition may reflect cross-reactivity with another source, or sensitization may remain clinically silent. Clinically relevant allergy requires a relationship between exposure and compatible manifestations, assessed through the clinical history and, where appropriate, additional investigations. Atopy denotes a personal or familial tendency to develop IgE sensitization, commonly to environmental proteins, and associated allergic disease. It is neither a synonym for every form of allergy nor a requirement for all allergic mechanisms; allergic contact dermatitis, for example, involves antigen-specific T cells rather than IgE.\n\nAllergens can be classified along several overlapping axes. Source-based categories include pollens, mites, foods, venoms, medicines, and contact chemicals. Exposure-based categories distinguish inhalation, ingestion, skin or mucosal contact, and introduction through stings or injections. Molecular classifications distinguish proteins, carbohydrate structures, and small chemicals that become immunologically active through interactions with host molecules. Mechanistic classifications separate IgE-mediated reactions from non-IgE immune responses, including T-cell-mediated delayed hypersensitivity. No single category determines the others: one source can contain several allergenic molecules, one molecule can be encountered by multiple routes, and material such as natural rubber latex can be associated with immediate allergy to proteins or delayed contact allergy to processing chemicals."
    },
    {
      "heading": "Molecular Properties and Allergen Nomenclature",
      "text": "Many characterized allergens are proteins belonging to families with conserved structures and biological functions. Plant pathogenesis-related class 10 (PR-10) proteins include the birch pollen allergen Bet v 1; related proteins occur in apple and hazelnut. Profilins are actin-binding proteins distributed throughout eukaryotes, with allergenic representatives in pollens and plant foods. Nonspecific lipid-transfer proteins, including peach Pru p 3, are small plant proteins whose disulfide bonds help stabilize their structure. Seed storage allergens include 2S albumins, such as peanut Ara h 2, and the 7S vicilins and 11S legumins, represented by peanut Ara h 1 and Ara h 3. These families differ in folding, solubility, and resistance to processing and digestion; family membership alone does not establish clinical allergenicity.\n\nAnimal allergens likewise occupy several distinct protein families. Tropomyosins are elongated, coiled-coil proteins associated with actin filaments; allergenic members occur in crustaceans, mites, and cockroaches. Their conserved sequences can support recognition across different species, although molecular similarity does not necessarily produce symptoms after every exposure. Lipocalins are small ligand-binding proteins with a characteristic beta-barrel structure. They include dog Can f 1, cat Fel d 4, and the mouse urinary allergen Mus m 1. Not all prominent mammalian allergens are lipocalins: cat Fel d 1 belongs to the secretoglobin family.\n\nAn epitope is the molecular region recognized by an immune receptor or antibody. A linear epitope consists of a continuous amino-acid sequence, whereas a conformational epitope depends on residues brought together by protein folding. Heating or chemical denaturation can disrupt conformational epitopes while leaving some linear epitopes accessible, or expose previously buried regions. Glycosylation adds carbohydrate structures that can themselves be recognized by IgE or influence protein folding and accessibility. Stability also affects whether an allergen remains intact during environmental exposure or digestion: many PR-10 proteins are relatively heat- and digestion-sensitive, whereas disulfide-stabilized lipid-transfer proteins and some storage proteins are more resistant. These are tendencies rather than universal rules. Some allergens also have enzymatic functions; the house dust mite allergen Der p 1 is a cysteine protease whose activity can disrupt epithelial junctional proteins in experimental systems.\n\nSmall chemicals may become allergenic through mechanisms unlike those of intact proteins. A hapten can acquire immunogenicity after association with a larger carrier, commonly through covalent attachment to a host protein. Reactive products of penicillin, for example, form protein-linked determinants recognized by the immune system. The resulting target may include both the chemical modification and adjacent protein structures. Metal ions need not form equivalent covalent complexes: nickel can coordinate with proteins and participate in interactions involving major histocompatibility complex molecules and T-cell receptors. Some drug hypersensitivity mechanisms likewise involve direct, noncovalent interactions with immune receptors rather than a conventional hapten–carrier conjugate.\n\nThe allergen nomenclature maintained by the World Health Organization and International Union of Immunological Societies (WHO/IUIS) identifies individual allergenic molecules rather than whole sources. Names generally combine the first three letters of the genus, the first letter of the species, and an Arabic number. Thus, Bet v 1 derives from Betula verrucosa, a name historically used for silver birch; Der p 1 derives from Dermatophagoides pteronyssinus; and Ara h 2 derives from Arachis hypogaea, peanut. Numbers distinguish allergens within a source and do not rank their potency or clinical importance. Extended numerical designations distinguish isoallergens and sequence variants. Recognition within this system requires supporting molecular and immunological evidence, but a registered name does not establish that the molecule causes disease in every sensitized person.\n\n“Major” and “minor” describe recognition frequency in a defined population. A major allergen is conventionally recognized by IgE from more than half of patients allergic to the relevant source; a minor allergen is recognized less frequently. These proportions depend on geography, exposure, patient selection, and assay methods. A minor allergen can still cause a severe reaction in an individual, while frequent IgE recognition of a major allergen is not itself a measure of reaction severity."
    },
    {
      "heading": "Immune Sensitization and Reaction Mechanisms",
      "text": "Sensitization begins when an allergen is encountered in an immune context that favors an allergic response rather than tolerance. At epithelial surfaces, dendritic cells take up allergenic material, process proteins into peptides, and display these peptides on class II major histocompatibility complex molecules to CD4-positive T cells, often in draining lymph nodes. Signals from injured or stimulated epithelial cells—including thymic stromal lymphopoietin, IL-25, and IL-33—can favor type 2 immunity through effects on dendritic cells and innate lymphoid cells. Under appropriate conditions, antigen-specific T cells differentiate into type 2 helper T cells and related follicular helper populations. Their signals support allergen-specific B cells: CD40 on the B cell engages CD40 ligand on an activated T cell, while IL-4, and in humans also IL-13, promote class-switch recombination toward immunoglobulin E (IgE). This changes the antibody’s constant region and effector function without changing its antigen-binding specificity.\n\nIgE secreted by antibody-producing plasma cells binds the high-affinity receptor FcεRI on mast cells in tissues and on circulating basophils. This receptor-bound IgE establishes a sensitized effector-cell population; receptor occupancy alone does not ordinarily cause degranulation. During a subsequent encounter, an allergen bearing appropriately arranged binding sites can cross-link adjacent IgE–FcεRI complexes. Receptor aggregation initiates intracellular signaling, calcium mobilization, and release of preformed granule contents, including histamine and, from mast cells, proteases such as tryptase. Activated cells also synthesize lipid mediators, including cysteinyl leukotrienes; mast cells are an important source of prostaglandin D₂. Mediators increase vascular permeability, stimulate sensory nerves and mucus secretion, and contract airway smooth muscle. Their distribution and extent of release help determine whether manifestations remain local or become systemic, as in anaphylaxis.\n\nThe immediate phase of an IgE-mediated reaction commonly begins within minutes, but its inflammatory consequences can outlast the initial mediator release. A late-phase response may become evident approximately four to eight hours after exposure and persist for a day or longer. Cytokines and chemokines produced by activated mast cells, T cells, and other local cells recruit eosinophils, basophils, and additional leukocytes. IL-5 supports eosinophil development and survival, while eotaxins help direct their migration into tissues. Eosinophil granule proteins and other inflammatory products can contribute to epithelial injury and sustained tissue reactivity. Repeated exposure may maintain chronic inflammation, although the cellular pattern varies among organs and allergic disorders; eosinophilia is not universal.\n\nNot all allergic reactions depend on IgE. In T-cell-mediated delayed hypersensitivity, antigen-specific memory T cells recognize antigen presented in tissues and release inflammatory cytokines or exert direct cytotoxic effects. Allergic contact dermatitis caused by nickel or certain fragrance chemicals illustrates this mechanism: inflammation typically develops over roughly 24–72 hours after re-exposure rather than within minutes through IgE-triggered degranulation. CD4-positive and CD8-positive T cells can both participate, with their relative contributions depending on the allergen. Some disorders, including atopic dermatitis and certain food-allergic conditions, involve overlapping antibody-associated, epithelial, and cellular pathways rather than a single uniform mechanism.\n\nExposure can instead produce immune tolerance, or no detectable adaptive response. Tolerogenic antigen presentation, deletion or functional inactivation of reactive lymphocytes, and suppression by regulatory T cells help restrain responses to otherwise harmless substances; IL-10 and transforming growth factor beta contribute to these regulatory environments. Conversely, immunological memory can sustain sensitization through allergen-specific memory T cells, memory B-cell populations capable of generating IgE-producing cells, and long-lived antibody-secreting cells. Persistence therefore does not depend solely on free IgE, whose serum half-life is approximately two to three days."
    },
    {
      "heading": "Inhaled Allergens",
      "text": "Airborne pollen carries allergenic proteins from grasses, trees, and weeds, particularly wind-pollinated plants that release large quantities into the air. Temperate grasses include timothy (Phleum pratense), perennial ryegrass (Lolium perenne), and orchard grass (Dactylis glomerata); representative molecules include the timothy allergens Phl p 1 and Phl p 5. Important tree sources include birch (Betula verrucosa, also classified as B. pendula), whose principal allergen is Bet v 1, and olive (Olea europaea), which produces Ole e 1. Short ragweed (Ambrosia artemisiifolia) is an important weed source, with Amb a 1 among its major allergens. Allergenic proteins become available when pollen hydrates on respiratory mucosa. Intact grains generally deposit in the upper airways, whereas smaller allergen-bearing particles released from pollen can penetrate farther into the lungs.\n\nHouse dust mites, especially Dermatophagoides pteronyssinus and D. farinae, produce allergens found in both fecal particles and material derived from their bodies. These mites inhabit reservoirs such as mattresses, bedding, carpets, and upholstered furniture. Their allergens include the cysteine proteases Der p 1 and Der f 1, the group 2 proteins Der p 2 and Der f 2, and Der p 23, a protein associated with the lining surrounding fecal pellets. Disturbing a reservoir can suspend allergen-bearing dust, creating an inhalation exposure without the mites themselves becoming airborne. Different mite molecules therefore reach the respiratory tract within heterogeneous biological particles rather than as a single, uniform substance.\n\nMammalian inhalant allergens originate chiefly in saliva, skin-associated secretions, and urine; hair acts mainly as a carrier rather than being the principal allergenic material. The cat allergen Fel d 1 is a secretoglobin produced particularly in salivary and sebaceous glands. Grooming distributes it onto the coat, from which it transfers to shed skin particles and dust. Dog allergens include the lipocalins Can f 1 and Can f 2, associated with saliva and dander, and Can f 5, a prostatic kallikrein found in urine. Rodent urinary proteins are particularly important in laboratory-animal facilities and some infested buildings: mouse Mus m 1 and rat Rat n 1 are lipocalins that can become airborne with contaminated bedding or dust. Allergenic material can also travel on clothing into buildings where the source animal is absent.\n\nAirborne fungal allergens occur in spores, hyphal fragments, and other fungal material. Alternaria alternata, commonly associated with vegetation and outdoor air, produces Alt a 1, an important marker of sensitization to this source. Aspergillus fumigatus produces multiple allergens, including Asp f 1, and releases small conidia capable of reaching the lower respiratory tract. Cladosporium and Penicillium species are additional sources. Allergic sensitization means immune recognition of fungal components and is distinct from fungal infection. Allergic bronchopulmonary aspergillosis is a specific hypersensitivity disorder involving airway colonization, principally in people with asthma or cystic fibrosis; it is not equivalent to invasive aspergillosis.\n\nCockroach allergens occur in feces, saliva, secretions, and shed body material. The German cockroach (Blattella germanica) produces allergens including Bla g 1 and Bla g 2; the American cockroach (Periplaneta americana) produces Per a 1 and the tropomyosin Per a 7. Contaminated household dust provides an inhalation route. Across these sources, exposure can elicit allergic rhinitis or contribute to allergic asthma in sensitized individuals. Neither disorder is necessarily allergic, however, and detecting sensitization to an airborne source alone does not establish that it causes a person’s respiratory symptoms."
    },
    {
      "heading": "Food Allergens",
      "text": "Widely recognized sources of food allergy include cow’s milk, hen’s egg, peanut, tree nuts, wheat, soy, fish, shellfish, and sesame. These are clinical source categories, not interchangeable molecular allergens: peanut is a legume, tree nuts comprise several botanical families, and shellfish include both crustaceans and molluscs. Allergy to one member of a category does not establish allergy to every member. Regulatory lists serve a different purpose by specifying foods subject to mandatory labeling. In the United States, sesame became the ninth legally designated major food allergen on January 1, 2023; the statutory categories distinguish crustacean shellfish from molluscs. The European Union specifies 14 categories of substances or products causing allergies or intolerances, including crustaceans and molluscs separately, as well as celery, mustard, lupin, and sulfites above a specified concentration. Neither list exhausts the foods capable of causing allergic reactions.\n\nIndividual foods contain multiple allergenic proteins with different structural properties. Cow’s-milk caseins, collectively designated Bos d 8, form much of the protein fraction of milk; whey allergens include β-lactoglobulin, Bos d 5. Egg-white ovomucoid, Gal d 1, is a protease inhibitor relatively resistant to heating and digestion, whereas ovalbumin, Gal d 2, is more heat-sensitive. Peanut seed-storage proteins include the 2S albumins Ara h 2 and Ara h 6, the 7S globulin Ara h 1, and the 11S globulin Ara h 3. Parvalbumins, small calcium-binding muscle proteins, are important allergens in many bony fish. Tropomyosins, which participate in muscle contraction, are major allergens in many crustaceans and molluscs, although other shellfish proteins also elicit reactions.\n\nProcessing changes allergen exposure without predictably abolishing it. Heating can unfold proteins and disrupt conformational epitopes, but it may leave linear epitopes intact or produce aggregates that retain antibody binding. Some people allergic to milk or egg tolerate extensively baked forms incorporated into a food matrix while reacting to less-heated forms; this is not a universal property of those foods. Roasting peanuts can promote glycation and aggregation rather than reliably reduce allergenicity. Digestive enzymes break proteins into peptides, but resistant proteins or fragments may retain immune recognition. Fermentation and enzymatic hydrolysis can reduce particular intact proteins, yet the extent depends on the organism, process, and starting material. Interactions with fats, carbohydrates, and other matrix constituents affect protein release, digestive accessibility, and the amount available for immune recognition.\n\nAlpha-gal syndrome provides an important exception to the predominance of protein food allergens. Its target, galactose-α-1,3-galactose, is a carbohydrate structure present on glycoproteins and glycolipids of non-primate mammals. Tick bites are associated with sensitization; in the United States, the lone star tick is a principal implicated species. Affected people may react to beef, pork, lamb, organ meats, or certain other mammalian products, with variable responses to dairy and gelatin. Unlike many immediate food reactions, symptoms after meat ingestion commonly begin about two to six hours later and can include urticaria, gastrointestinal symptoms, or anaphylaxis.\n\nIgE-mediated food allergy must be distinguished from other adverse responses to eating. Food protein-induced enterocolitis syndrome is an established non-IgE-mediated food allergy in which acute episodes typically involve repetitive vomiting one to four hours after ingestion, sometimes with lethargy and circulatory compromise. Food protein-induced allergic proctocolitis usually presents in infancy with blood-streaked stools. Celiac disease is an immune-mediated enteropathy triggered by gluten in genetically susceptible individuals, rather than IgE-mediated wheat allergy. Lactose intolerance instead results from insufficient digestion of the milk sugar lactose: intestinal fermentation and osmotic effects cause symptoms without an allergen-specific immune response."
    },
    {
      "heading": "Venoms, Latex, Medicines, and Contact Allergens",
      "text": "Honeybee and vespid venoms contain allergenic proteins delivered through stings into the skin and underlying tissues. In the honeybee, Apis mellifera, characterized allergens include phospholipase A2 (Api m 1), hyaluronidase (Api m 2), acid phosphatase (Api m 3), and icarapin (Api m 10). In the yellow jacket Vespula vulgaris, phospholipase A1 (Ves v 1) and antigen 5 (Ves v 5) are important allergens. These proteins differ in function: phospholipases act on membrane lipids, whereas hyaluronidases degrade hyaluronic acid in extracellular tissue. In sensitized individuals, venom proteins can cross-link cell-bound IgE and trigger reactions ranging from extensive local swelling to systemic anaphylaxis. Venom also causes pain and inflammation through nonallergic mechanisms; toxicity after numerous stings is distinct from allergy and can occur without prior sensitization.\n\nImmediate allergy to natural rubber latex targets proteins in the latex of Hevea brasiliensis, including Hev b 5 and the hevein-related allergen Hev b 6.02. Exposure can occur through contact with gloves or medical devices, mucosal contact, or inhalation of protein-bearing particles. Historically, cornstarch powder on medical gloves served as a carrier for airborne latex proteins. IgE-mediated reactions may include contact urticaria, respiratory symptoms, or anaphylaxis. This differs from delayed allergic contact dermatitis caused by rubber-processing chemicals, particularly accelerators such as thiurams, dithiocarbamates, and mercaptobenzothiazoles. These chemicals can also occur in synthetic rubber products that contain no natural latex proteins. Irritant hand dermatitis from friction, detergents, sweating, or prolonged glove use is a third, nonallergic condition.\n\nMedicines can become immune targets through several mechanisms. Small drug molecules often act as haptens: they bind to host proteins, creating structures recognized by antibodies or T cells. With penicillin, opening of the beta-lactam ring permits covalent attachment to proteins, producing penicilloyl determinants and other antigenic structures. Immediate reactions can involve IgE, while delayed eruptions can involve drug-reactive T cells. Recognition may depend on the beta-lactam core, degradation products, or side chains; consequently, allergy to one beta-lactam does not establish allergy to every member of the class. Other medicines can interact noncovalently with immune receptors or alter the peptides presented by major histocompatibility complex molecules. Drug metabolites, rather than the administered parent compound, may also provide the relevant immune target.\n\nCommon contact allergens include nickel, cobalt, chromium compounds, fragrance substances, preservatives, and hair-dye ingredients. Nickel ions released from jewelry or metal fasteners can participate in complexes recognized by T cells; hexavalent chromium in cement and chromium compounds associated with leather are established exposure sources. Fragrance allergens include oxidation products of limonene and linalool, illustrating how chemical change during storage can generate sensitizing substances. Preservatives include methylisothiazolinone and formaldehyde-releasing compounds, while p-phenylenediamine is an important allergen in oxidative hair dyes. Allergic contact dermatitis typically develops over hours to days after re-exposure and produces an eczematous eruption, rather than the rapid wheal-and-flare response characteristic of immediate contact urticaria.\n\nAn adverse drug reaction does not necessarily identify an allergen. Some medicines produce similar symptoms without antigen-specific immune recognition: vancomycin infusion reactions can involve direct mast-cell activation, while many cross-reactive reactions to nonsteroidal anti-inflammatory drugs result from cyclooxygenase-1 inhibition and altered inflammatory mediator production. Conversely, some reactions to individual drugs in that group are genuinely immune-mediated. Predictable pharmacological effects, gastrointestinal intolerance, and dose-related toxicity are also distinct from drug hypersensitivity. A rash occurring during antibiotic treatment may additionally reflect the underlying infection rather than immune recognition of the antibiotic."
    },
    {
      "heading": "Cross-Reactivity and Patterns of Multiple Sensitization",
      "text": "Cross-reactivity occurs when an antibody or immune-cell receptor recognizes shared or structurally similar epitopes on different molecules. In IgE-mediated allergy, antibodies generated against one allergen may therefore bind related proteins from another source, even without independent sensitization to that source. This differs from co-sensitization, in which separate immune responses develop against distinct allergens—for example, grass pollen and unrelated peanut storage proteins. Both processes can coexist. Multiple positive specific-IgE results consequently do not establish either multiple clinically relevant allergies or a single cross-reactive pathway. Sequence similarity can suggest possible cross-reactivity, but antibody binding also depends on the accessibility and three-dimensional arrangement of epitopes; laboratory recognition does not necessarily translate into symptoms during ordinary exposure.\n\nBirch-associated pollen–food syndrome illustrates cross-reactivity between homologous plant proteins. The principal birch pollen allergen, Bet v 1, belongs to the pathogenesis-related class 10, or PR-10, protein family. Related food allergens include Mal d 1 in apple and Cor a 1 in hazelnut. In some people sensitized to birch pollen, IgE recognizes these food proteins, producing itching or swelling of the lips, mouth, and throat after consumption. Many PR-10 proteins are susceptible to heating and digestion, helping explain why raw apple may cause symptoms while cooked apple is tolerated. This pattern is not universal, and systemic reactions can occur. Hazelnut also contains the storage proteins Cor a 9 and Cor a 14, whose recognition represents a different sensitization pattern from birch-associated Cor a 1 recognition. Profilins provide another route of pollen–food cross-reactivity because these actin-binding proteins occur widely in pollens and edible plants.\n\nTropomyosin, a conserved muscle protein in invertebrates, links sensitization to house dust mites, cockroaches, and shellfish. Representative allergens include Der p 10 from Dermatophagoides pteronyssinus, Bla g 7 from the German cockroach, and Pen a 1 from brown shrimp. Their related structures allow some IgE antibodies to bind proteins from several sources. Tropomyosin is relatively resistant to heating, so cooking does not reliably remove its capacity for IgE recognition. Nevertheless, mite sensitization is commonly directed against proteins other than tropomyosin, and mite allergy alone does not establish shellfish allergy. Even demonstrable IgE binding to both mite and shrimp tropomyosins does not prove that eating shrimp will cause a reaction. The direction of initial sensitization may also be difficult to determine from a single set of laboratory results.\n\nLatex–fruit cross-reactivity involves conserved plant proteins rather than a general relationship between rubber and all fruits. Associated foods include banana, avocado, chestnut, and kiwifruit, although the molecular basis varies among them. A well-characterized mechanism involves hevein, designated Hev b 6.02, from natural rubber latex and similar hevein-like domains in class I chitinases from foods such as avocado, banana, and chestnut. Other protein families can contribute: latex profilin, Hev b 8, can cross-react with pollen and food profilins. Thus, recognition of a latex extract may reflect antibodies to widely distributed plant proteins rather than clinically important latex allergy. Conversely, clinically relevant latex–fruit reactions cannot be inferred simply from botanical relatedness.\n\nCross-reactive carbohydrate determinants (CCDs) are sugar structures carried by otherwise unrelated glycoproteins. Classical plant and insect CCDs include N-linked glycans containing core α1,3-fucose or β1,2-xylose. IgE directed against these structures can bind multiple pollen, food, or insect-venom extracts, producing broad positive results in serum assays without corresponding clinical reactions in many cases. Their generally limited clinical relevance distinguishes them from the carbohydrate allergen alpha-gal, which can cause symptomatic allergy. Comparisons using nonglycosylated recombinant proteins or laboratory CCD-inhibition methods can help identify carbohydrate-driven binding; such findings still require interpretation alongside the exposure history."
    },
    {
      "heading": "Exposure, Distribution, and Population Patterns",
      "text": "Exposure depends on how allergenic material is released, transported, and retained, not simply on whether its source is present. Intact pollen grains, commonly tens of micrometres across, deposit predominantly in the upper airways; smaller allergen-bearing fragments can reach the lower respiratory tract. House dust mite material accumulates in mattresses, carpets, and upholstery and becomes airborne during disturbance, whereas some cat-allergen-bearing particles remain suspended longer and travel on clothing. Cat allergens are consequently detectable in schools and buildings without resident cats. Settled dust acts as a reservoir, but its allergen concentration is not equivalent to an inhaled dose. Humidity influences mite survival and fungal growth, while ventilation, furnishing, cleaning activity, and water damage alter indoor distributions. Outdoor exposure varies with flowering periods, daily release cycles, wind, and rainfall.\n\nSensitization and symptom elicitation are distinct outcomes of exposure. Sensitization involves development of an allergen-specific immune response; elicitation occurs when subsequent exposure activates an established response. Dose, repetition, route, and timing influence both processes, but there is no universal exposure threshold separating harmless contact from sensitization. Impaired skin barriers, particularly in eczema, can permit environmental food proteins to encounter immune cells under inflammatory conditions. By contrast, ingestion can support immune tolerance; randomized infant-feeding studies have demonstrated this for peanut in defined populations. These findings do not make exposure effects interchangeable across allergens or routes. Genetic susceptibility, age, existing inflammation, and concurrent environmental exposures also modify responses, and the dose that elicits symptoms varies among sensitized individuals.\n\nGeographic patterns reflect local vegetation, climate, housing, diet, and work. Birch sensitization is prominent in northern and central Europe, olive pollen is important around the Mediterranean, and ragweed is a major seasonal source in parts of North America and increasingly in parts of Europe. Mite exposure is generally greater in humid environments than in persistently dry ones, although indoor microclimates modify regional patterns. Food sensitization also varies with dietary practices and associated pollen exposure. Age matters: milk and egg allergy often begin in early childhood and may resolve, whereas sensitization to inhaled allergens commonly becomes more evident during childhood. In the United States, the 2005–2006 National Health and Nutrition Examination Survey found detectable specific IgE to at least one of 19 tested allergens in approximately 44% of people aged six years or older. This measured sensitization, not symptomatic allergy. Comparisons of prevalence require attention to participant selection, allergen panels, assay thresholds, and whether outcomes are self-reported symptoms, sensitization, or clinically established disease.\n\nOccupational settings can produce repeated, concentrated exposures. Bakers inhale wheat and rye proteins and added fungal enzymes such as alpha-amylase; laboratory-animal workers encounter urinary and other animal proteins, especially from rodents. Enzymes used in detergent manufacture and food processing can become airborne during handling. Certain wood dusts cause sensitization: western red cedar contains plicatic acid, a recognized cause of occupational asthma. Low-molecular-weight chemicals associated with occupational asthma include diisocyanates used in polyurethane production and acid anhydrides used in resins. Some act through interactions with host proteins, and demonstrable specific IgE is not present in every affected worker. Sensitizer-induced disease generally follows a latency period, whereas sufficiently intense irritant exposure can cause airway disease without allergen-specific sensitization. The same workplace aerosol may contain both sensitizing and irritating constituents.\n\nWeather changes exposure over hours and days, while climate change can alter flowering dates, season length, and plant distributions. A 2021 analysis of North American pollen records from 1990–2018 reported that pollen seasons began about 20 days earlier and annual pollen concentrations increased by approximately 21%. Trends differ among taxa and regions; warmer conditions do not increase every pollen source uniformly. Thunderstorms can create a different, acute exposure pattern: moisture can rupture susceptible pollen grains, releasing respirable allergen-bearing particles, while storm outflows concentrate and transport them near ground level. The November 2016 Melbourne thunderstorm-asthma event occurred during the grass-pollen season and generated thousands of emergency presentations. Such outbreaks depend on the conjunction of pollen availability, storm dynamics, and a susceptible population, rather than thunderstorms alone."
    },
    {
      "heading": "Establishing Clinical Relevance",
      "text": "Identifying a clinically relevant allergen requires agreement between exposure history, symptoms, and evidence of an appropriate immune response. The history establishes the suspected source, route of exposure, interval before symptoms, reproducibility, and circumstances in which exposure caused no reaction. Immediate IgE-mediated reactions commonly begin within minutes to a few hours, whereas allergic contact dermatitis develops later; alpha-gal-associated food reactions can also have a delayed onset. Exercise, alcohol, and some medicines can modify reaction thresholds. Alternative explanations include irritant exposure, infection, pharmacological effects, and nonimmune food intolerance. A positive sensitization test alone does not establish allergy, and its clinical significance depends on the probability suggested by the history.\n\nSkin-prick testing detects immediate cutaneous reactivity to allergen preparations, usually assessed against positive and negative controls. Serum allergen-specific IgE assays measure circulating antibodies recognizing material in an extract or a defined molecule. Both approaches identify sensitization rather than proving that ordinary exposure produces symptoms. Antihistamines can suppress skin responses, while extensive skin disease or dermographism can complicate interpretation; serum testing does not depend on an immediate skin response. Extracts differ in composition and may contain insufficient amounts of relevant proteins. Conversely, shared epitopes or cross-reactive carbohydrate structures can produce positive results for sources that cause no symptoms. Larger skin responses or higher specific-IgE concentrations may increase the probability of clinical allergy in defined populations, but do not reliably predict reaction severity. Indiscriminate testing of numerous unrelated sources increases the likelihood of clinically irrelevant positive findings.\n\nComponent-resolved diagnostics measures IgE recognition of individual allergenic molecules rather than only whole-source extracts. In peanut assessment, recognition of storage proteins such as Ara h 2 can support primary peanut allergy, whereas recognition of Ara h 8, a relative of birch Bet v 1, can indicate pollen-associated cross-reactivity. These patterns help explain otherwise ambiguous extract results, but neither pattern establishes an individual's reaction threshold or guarantees a particular severity. The 2023 European Academy of Allergy and Clinical Immunology guideline on diagnosis of IgE-mediated food allergy identifies component-specific IgE testing as useful in selected diagnostic settings. Interpretation remains dependent on the suspected food, population, age, and clinical history.\n\nPatch testing investigates delayed, predominantly T-cell-mediated contact allergy, not immediate IgE-mediated sensitization. Standardized preparations of substances such as nickel salts, fragrance chemicals, or preservatives are applied under controlled conditions, and subsequent skin responses are assessed at delayed readings. An allergic reaction must be distinguished from irritation, and a positive result must then be connected to a plausible current or previous exposure. For example, nickel sensitization may be relevant to dermatitis beneath metal fasteners but unrelated to a separate respiratory complaint. Patch testing and skin-prick testing therefore address different mechanisms and are not interchangeable.\n\nMedically supervised provocation tests assess whether controlled exposure produces a clinical reaction when history and sensitization tests leave uncertainty. Oral food challenge is the diagnostic reference standard for many food-allergy questions; blinded, placebo-controlled challenges are particularly useful when subjective symptoms or research requirements make bias important. Drug, nasal, conjunctival, and bronchial challenges have selected specialist applications. Because provocation can cause systemic reactions, including anaphylaxis, its use requires an appropriate clinical setting and risk assessment. A negative result establishes tolerance under the conditions tested, rather than guaranteeing absence of reactions under every future circumstance.\n\nSpecialist functional assays provide additional evidence without directly exposing the patient. The basophil activation test measures allergen-induced changes in activation markers, commonly CD63 or CD203c, using flow cytometry. Unlike a binding assay, it evaluates a cellular response and can improve discrimination between sensitization and clinical reactivity in selected settings. Its wider use is limited by sample-handling requirements, differences between laboratory protocols, incomplete availability, and individuals whose basophils respond inadequately to assay controls."
    },
    {
      "heading": "Laboratory Characterization, Measurement, and Standardization",
      "text": "Characterization commonly begins by extracting soluble proteins from a defined source under controlled conditions of pH, temperature, and ionic strength. Extraction conditions matter: buffers that recover water-soluble pollen proteins may poorly recover proteins embedded in fatty or heat-processed foods. Chromatography separates components by properties such as size, charge, or binding affinity; electrophoresis separates them principally by molecular mass under denaturing conditions. In immunoblotting, separated proteins are transferred to a membrane and probed with serum IgE from sensitized individuals. IgE binding identifies candidate allergens, but does not alone establish that a protein causes symptoms. Denaturation can also destroy conformational epitopes, leaving some allergens poorly represented on a blot.\n\nMass spectrometry identifies proteins through peptide masses and fragmentation patterns, usually after enzymatic digestion and comparison with sequence databases. Peptide sequencing, together with sequencing of the corresponding genes or transcripts, establishes molecular identity and helps distinguish related proteins and isoforms. Recombinant expression then permits production of individual molecules for structural studies, antibody-binding experiments, and diagnostic reagents. The production system affects the result: bacteria generally do not reproduce eukaryotic glycosylation, while other hosts may add different carbohydrate structures. Recombinant and naturally purified proteins therefore require comparison for folding, aggregation, and immune recognition rather than being assumed equivalent.\n\nRoutine measurement frequently uses enzyme-linked immunosorbent assays (ELISAs). In a sandwich assay, an immobilized antibody captures the target and a second antibody generates a measurable signal. Such assays quantify food-source proteins or individual environmental allergens, including mite Der p 1 and cat Fel d 1, in food extracts, settled dust, air-filter extracts, and manufacturing samples. Targeted liquid chromatography–tandem mass spectrometry instead measures characteristic peptides, often using isotope-labelled internal standards. It can distinguish several sources in one analysis, but peptide selection must account for related species, processing-induced modifications, and incomplete digestion. Dust concentrations expressed per gram of dust are not interchangeable with airborne concentrations expressed per cubic metre; surface-swab results additionally depend on the sampled area and collection efficiency.\n\nPolymerase chain reaction detects DNA associated with an allergenic source, not the allergenic protein itself. Detection of peanut DNA, for example, supports the presence of peanut-derived material but does not directly quantify Ara h 2 or its IgE-binding activity. Protein-rich fractions can contain little recoverable DNA, while DNA may remain detectable when proteins have been extensively altered. Heating, fermentation, and chemical treatment affect DNA and proteins differently. Uneven contamination also makes sampling critical: a negative result from a small subsample cannot establish absence throughout a production batch.\n\nQuantitative results depend on calibration, reference materials, and a clearly defined measurand—such as milligrams of total peanut protein per kilogram of food rather than milligrams of peanut ingredient. The detection limit concerns the smallest signal distinguishable from background; the quantification limit additionally requires acceptable quantitative performance. Recovery experiments assess how much added target survives extraction and measurement, although freshly added material may behave differently from material incorporated before cooking. Matrix components can inhibit extraction, obscure antibody binding, or suppress ionization in mass spectrometry. These effects contribute to measurement uncertainty and can produce disagreement between methods targeting different proteins.\n\nDiagnostic and therapeutic extracts require control of identity, composition, potency, and stability. Source species, cultivation or collection conditions, extraction procedures, and storage can change their molecular composition; proteases in some extracts can degrade other components in mixtures. In the United States, standardized extracts are compared with FDA reference preparations through specified procedures and labelled in units such as allergy units or bioequivalent allergy units, depending on the product. These units are not universally interchangeable across sources or manufacturers. Total protein mass likewise does not establish biological potency: extracts with similar protein concentrations may contain different amounts of clinically relevant allergens. Component-specific assays complement overall potency measurements by revealing underrepresentation or loss of individual molecules."
    },
    {
      "heading": "Exposure Control, Food Regulation, and Therapeutic Uses",
      "text": "Institutional exposure control targets allergen sources and the routes by which allergenic material reaches people. In workplaces handling flour, enzymes, or laboratory animals, measures include substituting less dusty preparations, enclosing transfer processes, installing local exhaust ventilation, and using ventilated animal cages. These engineering controls reduce release or capture material near its source rather than relying solely on personal protective equipment. In food production, allergen cross-contact means unintended incorporation of an allergen into another food. Controls include segregation of ingredients, dedicated equipment where appropriate, production scheduling, management of reworked food, and validated cleaning procedures. Supplier specifications and label checks address a different failure mode: an allergenic ingredient may be present intentionally but omitted from the finished product’s declaration.\n\nIngredient declarations identify a food’s formulated ingredients, whereas mandatory allergen rules require specified sources to be recognizable even when ingredient names would otherwise obscure them. In the United States, the Food Allergen Labeling and Consumer Protection Act of 2004 established requirements for eight major food-allergen sources; the FASTER Act of 2021 added sesame, effective January 1, 2023. The resulting nine are milk, egg, fish, crustacean shellfish, tree nuts, peanuts, wheat, soybeans, and sesame. For packaged foods subject to these requirements, the source generally appears within the ingredient list or in an adjacent “Contains” statement. Fish species, crustacean species, and specific tree-nut types must also be identified. These statutory categories are not an exhaustive inventory of foods capable of causing food allergy.\n\nIn the European Union, Regulation (EU) No 1169/2011 requires declaration of 14 categories of substances or products causing allergies or intolerances, with relevant names emphasized in the ingredient list; allergen information is also required for non-prepacked foods. The categories include celery, mustard, lupin, and molluscs, which are not among the nine United States major allergens. Sulphur dioxide and sulphites are included above 10 mg/kg or 10 mg/litre, expressed as total sulphur dioxide; their inclusion illustrates that the regulation covers intolerance as well as allergy. Precautionary allergen labeling, such as “may contain,” addresses possible unintended presence rather than an intentional ingredient. Such statements are generally voluntary in both jurisdictions and do not communicate a uniform, quantified probability or dose of exposure.\n\nNeither visual cleanliness nor ordinary cleaning establishes the absence of allergenic proteins. Residues can remain on equipment, move through shared utensils, or be distributed unevenly through a food batch. Cleaning effectiveness depends on the food matrix, surface, cleaning chemistry, and physical removal; microbial sanitation alone does not demonstrate allergen removal. Validation therefore concerns a specified process and residue, not merely whether equipment looks clean. Likewise, “hypoallergenic” does not establish the absence of all clinically relevant allergens. Its meaning depends on the product category and applicable rules, and a reduced amount or altered preparation may still contain molecules recognized by sensitized individuals.\n\nAllergen immunotherapy deliberately administers an implicated allergen to modify subsequent responses. Subcutaneous immunotherapy uses injections of allergen extracts; sublingual immunotherapy uses preparations held under the tongue, including standardized tablets for selected pollen and house-dust-mite allergies. Venom immunotherapy similarly uses insect-venom preparations to reduce the risk of systemic reactions to later stings. Repeated administration can alter allergen-specific T-cell responses and increase blocking antibodies, particularly IgG4, alongside changes in effector-cell responsiveness. Selected food-allergy approaches, especially oral immunotherapy, administer measured quantities of a food allergen to raise the reaction threshold. Desensitization denotes reduced responsiveness maintained during regular treatment; sustained unresponsiveness denotes nonreactivity demonstrated after a defined period without treatment. The latter is not equivalent to permanent tolerance.\n\nAllergen-specific treatment differs from suppression of symptoms or broader immune pathways. Antihistamines block histamine receptors, while corticosteroids reduce inflammatory activity without targeting one allergen. The anti-IgE monoclonal antibody omalizumab reduces available IgE and associated effector-cell activation; in 2024, the United States approved it for reducing allergic reactions from accidental food exposure in eligible patients aged one year and older. It is neither allergen-specific immunotherapy nor emergency treatment. Epinephrine, used in anaphylaxis, acts on the acute physiological consequences of a reaction rather than eliminating sensitization."
    },
    {
      "heading": "Historical Development of Allergen Science",
      "text": "Charles Harrison Blackley helped establish pollen as a cause of hay fever through investigations published in his 1873 book Experimental Researches on the Causes and Nature of Catarrhus Aestivus. A physician who himself experienced hay fever, Blackley applied pollen to the conjunctiva, nasal mucosa, and skin, documenting the resulting local reactions. He also collected airborne pollen on adhesive-coated slides and used elevated sampling devices, including kites, to investigate its distribution. By relating pollen exposure to symptoms and seasonal occurrence, his work supplied experimental evidence against explanations centered on heat, odors, or dust generally. These studies preceded an immunological account of why only some exposed people developed symptoms.\n\nIn 1906, the Austrian pediatrician Clemens von Pirquet introduced the term allergy to describe altered reactivity following previous exposure to a substance. His concept arose from observations of infectious disease, vaccination, and serum sickness, including work with Béla Schick on reactions to therapeutic sera. Its original scope included changes that could be protective as well as harmful; it was not restricted to immediate hypersensitivity. As immunology developed, protective acquired immunity and allergic disease became more clearly distinguished. In modern usage, allergy denotes immunologically mediated hypersensitivity, while “allergen” identifies an antigen capable of eliciting allergic responses rather than simply any substance encountered by the immune system.\n\nLeonard Noon’s 1911 paper “Prophylactic inoculation against hay fever,” published in The Lancet, introduced a systematic approach to treating pollen-associated disease with injections of pollen extract. Noon assessed patients’ sensitivity using conjunctival responses and administered progressively adjusted extract doses, seeking to increase resistance to subsequent exposure. John Freeman continued this work after Noon’s early death. These investigations became a foundation for allergen immunotherapy, although their early rationale preceded recognition of the relevant antibody and cellular mechanisms. Subsequent clinical practice expanded the use of extracts from pollens, mites, animal sources, and venoms. Differences in extraction methods, composition, and biological activity later made extract characterization and standardization important scientific and regulatory tasks.\n\nThe identification of immunoglobulin E (IgE) transformed explanations of immediate allergy. In 1921, Carl Prausnitz and Heinz Küstner had demonstrated that a serum factor could transfer immediate skin sensitivity, but the identity of this “reagin” remained unresolved for decades. In 1966, Kimishige and Teruko Ishizaka and their collaborators reported evidence that reaginic activity belonged to a previously unrecognized immunoglobulin class. Independently, S. Gunnar O. Johansson and Hans Bennich characterized an unusual myeloma immunoglobulin reported in 1967; comparison established its relationship to the Ishizakas’ antibody. The designation IgE was internationally accepted in 1968. In 1967, Leif Wide, Bennich, and Johansson described the radioallergosorbent test, which used allergen-bearing solid material and labeled anti-IgE to detect allergen-specific antibodies in serum. This provided a laboratory means of measuring sensitization, rather than establishing clinical disease solely from a positive result.\n\nFrom the later twentieth century, chromatographic purification, protein sequencing, and recombinant DNA methods shifted research from whole-source extracts toward individual allergenic molecules. Cloning of the major birch pollen allergen Bet v 1 was reported in 1989, enabling production and detailed investigation of a defined molecule rather than an unresolved pollen mixture. Structural studies subsequently connected antibody recognition with protein shape and shared epitopes. International nomenclature developed alongside this work: a joint WHO/International Union of Immunological Societies nomenclature report appeared in 1986. Names such as Bet v 1 and Der p 1 linked molecules to their source organisms and assigned numbers, providing a common vocabulary for comparing purified, recombinant, and structurally characterized allergens."
    }
  ],
  "links": [
    "immune-system",
    "allergy",
    "protein",
    "antibody",
    "t-cell",
    "diagnosis",
    "antigen",
    "food-allergy",
    "epitope",
    "protein-folding",
    "penicillin",
    "world-health-organization",
    "dendritic-cell",
    "major-histocompatibility-complex",
    "b-cell",
    "class-switch-recombination",
    "plasma-cell",
    "anaphylaxis",
    "inflammation",
    "eczema",
    "immune-tolerance",
    "regulatory-t-cell",
    "immunological-memory",
    "fungi",
    "allergic-rhinitis",
    "asthma",
    "united-states",
    "european-union",
    "carbohydrate",
    "urticaria",
    "humidity",
    "prevalence",
    "weather",
    "climate-change",
    "chromatography",
    "mass-spectrometry",
    "recombinant-dna",
    "polymerase-chain-reaction",
    "calibration",
    "measurement-uncertainty",
    "antihistamine",
    "corticosteroid",
    "monoclonal-antibody",
    "epinephrine"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}